Patient Perspectives on Use of Stem Cells to Treat Osteoporosis
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2020, Vol 1, Issue 1
Abstract
Osteoporosis is a systemic skeletal disease leading to increased risk of fragility fractures. These fractures lead to significant patient morbidity, increased mortality and substantial health and social care costs. The use of stem cells for cell-based therapies is currently an exciting, promising and growing area for disease treatment and regenerative medicine. However, the attitudes of participants towards the use of stem cells for regenerative medicine applications, particularly for therapeutic interventions amongst the older population, have not been well explored. This study explored patient perceptions of a proposed new treatment utilising a novel orthobiologic stem cell therapy. An online questionnaire for participants affected by osteoporosis was designed using the ‘Bristol Online Survey’ tool. In addition, three focus groups were held to explore a number of the issues raised by the findings in more depth. Findings showed that acceptability for the new treatment was high, as current treatments were variable in their effectiveness and new treatments were keenly welcomed. Participants indicated a willingness to have the proposed treatment in order to reduce their chance of experiencing a fracture, regardless of whether the treatment would reduce existing pain, or improve existing quality of life. The use of both autologous and allogeneic stem cells was acceptable, with slight differences in opinion indicating reservations regarding the potentially painful nature of stem cell extraction and allogeneic stem cell rejection. The findings demonstrated a clear mandate to the research team (and community) to continue their efforts in developing stem cell-based treatments for bone repair applications.
Authors and Affiliations
Hilary Isla Brown, Tom Clutton-Brock, Dawn-Marie Walker, Opinder Sahota, Brigitte E Scammell, Ifty Ahmed
Keywords
Related Articles
- EP ID EP698845
- DOI http://dx.doi.org/10.46889/JRMBR.2020.1106
- Views 79
- Downloads 0
Stem Cell Treatment for Acute Lymphoblastic Leukemia in Adults
Stem cell therapy used to treat Acute Lymphoblastic Leukemia in adults (ALL) has been one of the more promising uses of stem cells and has large implications on the survival rate of adults with ALL. While the survival ra...
Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-II
This literature review analyzes the results from studies applying conditioned medium and extracellular vesicles derived from the mesenchymal stem cell secretome to numerous disease states in animal and human in-vivo mode...
Management of Resistant Endometrium in Cases of Recurrent Implantation Failure Using Endometrial Mesenchymal Stem Cells as an Innovative Regenerative Therapy-A Short Communication
Currently the most accepted definition of Recurrent Implantation Failure (RIF) ,is the absence of achieving clinical pregnancy following transfer of 3 or more good quality embryos in women under 35 years age as well as...
The Future Role of Mesenchymal Stem Cells in Tissue Repair and Medical Therapeutics: Realities and Expectations
Mesenchymal Stem Cells (MSCs); which were first described by Alexander Fridenstein in the 1960s; are heterogeneous, non-hematopoietic, adult multipotent stromal progenitor cells that are capable of self-renewal and dif...
A Regenerative Interventional Approach to the Management of Degenerative Low Back Pain
Objective: Low back pain has been strongly related to the degenerative process of the spine, especially the degeneration of the intervertebral disc and facet joints. The main procedures for the management of low back pai...